According to a new report, the amount of American lives altered by Alzheimer’s disease (AD) continues to grow. Researchers discovered that roughly 5+ million Americans had Alzheimer’s or mild cognitive impairment (MCI) as a result of the disease in 2017. The report also revealed that 16 million people will be living with Alzheimer’s by 2050.
We vehemently oppose any mischaracterization of how Avanir and other members of the pharmaceutical industry interact with the medical community, including physicians that educate other health care professionals about medicines. Pat
We stand proudly by our commitment to research and development of treatments for CNS disorders and our relationships with advocacy organizations in our overarching commitment to help and support these patients and care communities